Figure 3
Figure 3. Deficiency of GM-CSF signaling is favorable for the development of RUNX1-ETO–induced leukemia. (A) Kaplan-Meier survival curve of animals transplanted with βc−/− cells transduced with MigR1 or MigRE. Pooled results from 4 different transplantation experiments are shown. (B) Immunoblotting analysis of spleen cells from βc−/− MigRE leukemia animals using anti-HA tag (RUNX1-ETO) Ab. MigRE is a positive control. Wild-type (WT) is a negative control. (C) Kaplan-Meier survival curve of animals transplanted with βc−/− or βc+/+ cells transduced with MigR1 or MigRE. (D) Kaplan-Meier survival curve of animals transplanted with βc−/− or βc+/+ cells transduced with MigR1 or MigRE9a vectors.

Deficiency of GM-CSF signaling is favorable for the development of RUNX1-ETO–induced leukemia. (A) Kaplan-Meier survival curve of animals transplanted with βc−/− cells transduced with MigR1 or MigRE. Pooled results from 4 different transplantation experiments are shown. (B) Immunoblotting analysis of spleen cells from βc−/− MigRE leukemia animals using anti-HA tag (RUNX1-ETO) Ab. MigRE is a positive control. Wild-type (WT) is a negative control. (C) Kaplan-Meier survival curve of animals transplanted with βc−/− or βc+/+ cells transduced with MigR1 or MigRE. (D) Kaplan-Meier survival curve of animals transplanted with βc−/− or βc+/+ cells transduced with MigR1 or MigRE9a vectors.

Close Modal

or Create an Account

Close Modal
Close Modal